ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 81, Issue 1, 1998, Pages 117-121

  Houlden, Henry ^a   Crook, Richard ^a   Backhovens, Hubert ^b   Prihar, Guy ^a   Baker, Matt ^a   Hutton, Mike ^a   Rossor, Martin ^c   Martin, Jean Jacques ^d   Van Broeckhoven, Christine ^b   Hardy, John ^a  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Alzheimer's disease; ApoE; Genetics; Presenilins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 14; CLINICAL PROTOCOL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MUTATION; PRESENILIN-1; PRESENILIN-2; RISK FACTORS;

EID: 18144435730     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980207)81:1<117::AID-AJMG19>3.0.CO;2-M     Document Type: Article

References (9)

1. American College of Medical Genetics (ACMG/American Society of Human Genetics (ASHG) Working Group on Apolipoprotein E and Alzheimer's Disease (1996): Statement on the use of apolipoprotein E testing for Alzheimer's disease. JAMA 274:1627-1629.
2. Campion D, Flaman JM, Brice A, Mannequin D, Dubois B, Martin C, Moreau V, Charbonnier F, Didierjean O, Tardieu S, Penet C, Fuel M, Pasquier F, Ledoze F, Bellis G, Calenda A, Heilig R, Martinez M, Mallet J, Bellis M, Clergetdarpoux F, Agid Y, Frebourg T (1995): Mutations at the presenilin 1 gene families with early-onset Alzheimer's disease. Hum Mol Genet 4:1365-1369.
3. Clark R, Hutton M, Fuldner RA, Alzheimer's Disease Collaborative Group (1995): The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early-onset AD families. Nat Genet 11:219-222.
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993): Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
5. Crook R, Hardy J, Duff K (1994): Single day ApoE genotyping. J Neurosci Methods 53:125-127.
6. Cruts M, Backhovens H, Vangassen G, Theuns J, Wang SY, Wehnert A, Van Duijn CM, Karlsson T, Hofman A, Adolfsson R, Martin JJ, Van Broeckhoven C (1995): Genetic and physical characterization of the early-onset Alzheimer's disease AD3 locus on chromosome 14q24,3. Hum Mol Genet 4:1355-1364.
7. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani I., Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991): Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
8. Hann J, Van Broeckhoven C, Van Duijn C, Voorhoeve E, Van Harskamp F, Van Swieten JC, Maat Schieman ML, Roos RA, Bakker E (1994): The apolipoprotein E e4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations. Ann Neurol 34:434-437.
9. Houlden H, Collinge J, Kennedy A, Newton S, Rossor M, Lannfelt L, Lilius L, Winblad B, Crook R, Duff K, Hardy J (1993a): ApoE genotype is a determinate of onset age in families with Alzheimer's disease and APP mutations. Lancet 342:737-738.